Cargando…
The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease
Alzheimer’s disease (AD) was first identified more than 100 years ago, yet aspects pertaining to its origin and the mechanisms underlying disease progression are not well known. To this date, there is no therapeutic approach or disease-modifying drug that could halt or at least delay disease progres...
Autores principales: | de Lima, Izabella B.Q., Ribeiro, Fabíola M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190153/ https://www.ncbi.nlm.nih.gov/pubmed/34951388 http://dx.doi.org/10.2174/1570159X20666211223140303 |
Ejemplares similares
-
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
por: Abd-Elrahman, Khaled S., et al.
Publicado: (2023) -
Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes
por: Spampinato, Simona Federica, et al.
Publicado: (2015) -
Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
por: Spampinato, Simona Federica, et al.
Publicado: (2018) -
Group I Metabotropic Glutamate Receptor-Mediated Gene Transcription and Implications for Synaptic Plasticity and Diseases
por: Wang, Hansen, et al.
Publicado: (2012) -
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data
por: Celli, Roberta, et al.
Publicado: (2023)